Examiner Tiwari Vyoma Shubham

1634-TIWARI-VYOMA-SHUBHAM

Employment Information

Art Unit:1634 — Chemistry: molecular biology and microbiology
Group:1630 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
Classes: 424 — Drug, bio-affecting and body treating compositions
435 — Chemistry: molecular biology and microbiology
800 — Multicellular living organisms and unmodified parts thereof and related processes
Phone:Available with subscription
Email:Available with subscription
Title:Pat Examnr (Biology)
Service:4 years
Grade:GS-09

Grant Rate and Difficulty Ranking

93
3-Year Grant rate: 21% over 39 cases
Difficulty: Extremely Hard
Difficulty Percentile: 93rd

With Examiner Tiwari, you have a 21% chance of getting an issued patent by 3 years after the first office action. Examiner Tiwari is an extremely hard examiner and in the 93rd percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Tiwari, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1634

Examiner Tiwari's grant rate is lower than that of Art Unit 1634 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Tiwari 2.3
Art Unit 1634 2.2

Interview Benefit

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Recent Dispositions

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeal History

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.

Loading...